yttrium 90 microspheres
boston scientific
[]
new #epoch analyses presented by &amp; medonc dr harris #gi23 showed longer pfs, hpfs &amp; qol benefits in 2l #mcrc subgroups treated w/ tare+chemo compared to tare+chemo treated pts in full itt population. learn more: #therasphere 
President, Interventional Oncology & Embolization at Boston Scientific, Peripheral Interventions @bsc_pi